Immunotech Biopharm Ltd

Immunotech Biopharm Ltdverified

6978.HK

Price:

$3.53

Market Cap:

$1.67B

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymph...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

HKSE

Ticker

6978.HK

The PE Ratio as of May 2025 (TTM) for Immunotech Biopharm Ltd (6978.HK) is -9.05

According to Immunotech Biopharm Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -9.05. This represents a change of -99.68% compared to the average of -2814.30 of the last 4 quarters.

Immunotech Biopharm Ltd (6978.HK) Historical PE Ratio (quarterly & annually)

How has 6978.HK PE Ratio performed in the past?

The mean historical PE Ratio of Immunotech Biopharm Ltd over the last ten years is -43.67. The current -9.05 PE Ratio has changed 1.97% with respect to the historical average. Over the past ten years (40 quarters), 6978.HK's PE Ratio was at its highest in in the December 2024 quarter at -2.94. The PE Ratio was at its lowest in in the June 2019 quarter at -25477.92.

Quarterly (TTM)
Annual

Average

-43.67

Median

-9.03

Minimum

-195.38

Maximum

-5.95

Immunotech Biopharm Ltd (6978.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immunotech Biopharm Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 108.23%

Maximum Annual PE Ratio = -5.95

Minimum Annual Increase = -85.94%

Minimum Annual PE Ratio = -195.38

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.95-7.16%
2023-6.417.44%
2022-5.96-68.28%
2021-18.80108.23%
2020-9.03-85.94%
2019-64.19-67.15%

Immunotech Biopharm Ltd (6978.HK) Average PE Ratio

How has 6978.HK PE Ratio performed in the past?

The current PE Ratio of Immunotech Biopharm Ltd (6978.HK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.11

5-year avg

-9.23

10-year avg

-43.67

Immunotech Biopharm Ltd (6978.HK) PE Ratio vs. Peers

How is 6978.HK’s PE Ratio compared to its peers?

Immunotech Biopharm Ltd’s PE Ratio is greater than Ocumension Therapeutics (-14.90), greater than Akeso, Inc. (-128.35), less than Kintor Pharmaceutical Limited (0), greater than Peijia Medical Limited (-14.49), less than Alphamab Oncology (38.80),

Build a custom stock screener for Immunotech Biopharm Ltd (6978.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunotech Biopharm Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunotech Biopharm Ltd (6978.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunotech Biopharm Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immunotech Biopharm Ltd's PE Ratio?

How is the PE Ratio calculated for Immunotech Biopharm Ltd (6978.HK)?

What is the highest PE Ratio for Immunotech Biopharm Ltd (6978.HK)?

What is the 3-year average PE Ratio for Immunotech Biopharm Ltd (6978.HK)?

What is the 5-year average PE Ratio for Immunotech Biopharm Ltd (6978.HK)?

How does the current PE Ratio for Immunotech Biopharm Ltd (6978.HK) compare to its historical average?